Literature DB >> 17503481

The opioid system in alcohol and drug dependence: family-based association study.

Xiaoling Xuei1, Leah Flury-Wetherill, Laura Bierut, Danielle Dick, John Nurnberger, Tatiana Foroud, Howard J Edenberg.   

Abstract

Opioid receptors and their endogenous peptide ligands play important roles in neurotransmission and neuromodulation in response to addictive drugs such as heroin, cocaine, and alcohol. In an earlier study, we reported that variation in the genes encoding the kappa-opioid receptor (OPRK1) and its peptide ligand (PDYN) were associated with the risk for alcoholism. We continued our investigation of the role of the opioid system in alcohol dependence by analyzing the genes encoding the micro- and delta-opioid receptors and their peptide ligands. We analyzed 18 OPRM1 SNPs, 18 OPRD1 SNPs, 7 PENK SNPs, and 7 POMC SNPs in a sample of 1923 European Americans from 219 multiplex alcohol dependent families. Employing a family-based test of association, we found no evidence that these four genes were significantly associated with alcohol dependence. We also did not find association between these genes and illicit drug dependence. Secondary analyses employing the narrower phenotype of opioid dependence (83 affected individuals) demonstrated association with SNPs in PENK and POMC, but not in OPRM1 or OPRD1. Haplotype analyses provided further support for the association of PENK and POMC with opioid dependence. Therefore, our data provide no support for the idea that variations in OPRM1, OPRD1, PENK and POMC are associated with alcohol dependence or general illicit drug dependence, but variations in PENK and POMC appear to be associated with the narrower phenotype of opioid dependence in these families. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503481     DOI: 10.1002/ajmg.b.30531

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  38 in total

Review 1.  Genetics of alcoholism.

Authors:  Priya A Iyer-Eimerbrink; John I Nurnberger
Journal:  Curr Psychiatry Rep       Date:  2014-12       Impact factor: 5.285

Review 2.  Candidate gene polymorphisms predicting individual sensitivity to opioids.

Authors:  Shinya Kasai; Masakazu Hayashida; Ichiro Sora; Kazutaka Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

Review 3.  Pharmacogenetics of OPRM1.

Authors:  Richard C Crist; Wade H Berrettini
Journal:  Pharmacol Biochem Behav       Date:  2013-11-05       Impact factor: 3.533

Review 4.  Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment.

Authors:  Vadim Yuferov; Orna Levran; Dmitri Proudnikov; David A Nielsen; Mary Jeanne Kreek
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 5.  The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review.

Authors:  Lara A Ray; Christina S Barr; Julie A Blendy; David Oslin; David Goldman; Raymond F Anton
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

6.  Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence.

Authors:  Matthew Randesi; Wim van den Brink; Orna Levran; Peter Blanken; Eduardo R Butelman; Vadim Yuferov; Joel Correa da Rosa; Jurg Ott; Jan M van Ree; Mary Jeanne Kreek
Journal:  Drug Alcohol Depend       Date:  2016-09-05       Impact factor: 4.492

7.  Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.

Authors:  Toni-Kim Clarke; Richard C Crist; Kyle M Kampman; Charles A Dackis; Helen M Pettinati; Charles P O'Brien; David W Oslin; Thomas N Ferraro; Falk W Lohoff; Wade H Berrettini
Journal:  Neurosci Lett       Date:  2013-02-20       Impact factor: 3.046

8.  An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.

Authors:  Richard C Crist; Toni-Kim Clarke; Alfonso Ang; Lisa M Ambrose-Lanci; Falk W Lohoff; Andrew J Saxon; Walter Ling; Maureen P Hillhouse; R Douglas Bruce; George Woody; Wade H Berrettini
Journal:  Neuropsychopharmacology       Date:  2013-04-23       Impact factor: 7.853

9.  Can we identify genes for alcohol consumption in samples ascertained for heterogeneous purposes?

Authors:  Narelle K Hansell; Arpana Agrawal; John B Whitfield; Katherine I Morley; Scott D Gordon; Penelope A Lind; Michele L Pergadia; Grant W Montgomery; Pamela A F Madden; Richard D Todd; Andrew C Heath; Nicholas G Martin
Journal:  Alcohol Clin Exp Res       Date:  2009-01-22       Impact factor: 3.455

10.  OPRM1 Asn40Asp predicts response to naltrexone treatment: a haplotype-based approach.

Authors:  Gabor Oroszi; Raymond F Anton; Stephanie O'Malley; Robert Swift; Helen Pettinati; David Couper; Qiaoping Yuan; David Goldman
Journal:  Alcohol Clin Exp Res       Date:  2008-11-25       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.